A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)
Clinical trial NCT01702298 · COMPLETED
Trial details
- NCT number
- NCT01702298
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-07
- Primary completion
- 2013-05-29
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.